Publication | Closed Access

Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles–mumps–rubella–varicella vaccine to children aged 11–21 months

VaccinologyVaccinationVaccine SafetyMucosal VaccinationMeasles–mumps–rubella–varicella VaccineVaccine DevelopmentImmunologyVaccine TestingImmediate PainMedicineVaccine Research